Tumor cells can avoid clearance by the immune system through a series of mechanisms, such as developing an immunosuppressive microenvironment and expressing programmed cell death ligand-1 (PDL-1) on the cell surface to counteract T cells. This evidence concerns the gene CD274 and neoplasm.